+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Angioplasty Balloons Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 260 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994221
The angioplasty balloons market was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 3.4% from 2024 to 2033.

Angioplasty balloon is a minimally invasive endovascular device is used to open up blocked or narrowed blood vessels. This device enables to restore proper blood flow, alleviating the symptoms of coronary artery disease, heart attacks, and other cardiac diseases. The procedure is generally less expensive than open heart surgery, making it a cost-effective option for many patients.

The growth of the global angioplasty balloons market is driven by alarming increase in prevalence of cardiovascular diseases. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases. As per the article published by the Revista Española de Cardiología - the official publication of the Spanish Society of Cardiology - coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers like angioplasty due to quicker recovery times and reduced hospital stays foster the growth of the market. However, high cost of angioplasty and complications associated with angioplasty, such as arterial dissection or restenosis hamper the market growth. On the contrary, continuous improvements in balloon design, materials, and imaging technologies will enhance the efficacy and safety of angioplasty procedures, which are expected to offer remunerative opportunities for the expansion of the market during the forecast period.

The global angioplasty balloons market is segmented into type, application, end user, and region. On the basis of type, the market is classified into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. By application, it is bifurcated into peripheral and coronary. Depending on end user, it is segregated into ASCs, hospitals, and Cath labs. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the normal balloon segment was the major revenue generator in 2023.

By application, the coronary segment accounted for the largest share in 2023 in angioplasty balloons market.

Depending on end user, the ASCs segment held the was the key shareholder in 2023.

Region wise, North America generated the highest revenue in 2023 and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global angioplasty balloons market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc, MEDTRONIC PLC., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Normal Balloons
  • Drug Eluting Balloons
  • Cutting Balloons
  • Scoring Balloons

By Application

  • Peripheral
  • Coronary

By End User

  • ASCs
  • Hospitals
  • Cath Labs

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc
  • MEDTRONIC PLC.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • THE SPECTRANETICS CORPORATION

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ANGIOPLASTY BALLOONS MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Normal Balloons
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Drug Eluting Balloons
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Cutting Balloons
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Scoring Balloons
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Peripheral
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Coronary
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: ANGIOPLASTY BALLOONS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. ASCs
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Hospitals
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Cath Labs
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: ANGIOPLASTY BALLOONS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Angioplasty Balloons Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Angioplasty Balloons Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Angioplasty Balloons Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Angioplasty Balloons Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Angioplasty Balloons Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Angioplasty Balloons Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Angioplasty Balloons Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Angioplasty Balloons Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Angioplasty Balloons Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Angioplasty Balloons Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Angioplasty Balloons Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Angioplasty Balloons Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Angioplasty Balloons Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Angioplasty Balloons Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Angioplasty Balloons Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Angioplasty Balloons Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Angioplasty Balloons Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Angioplasty Balloons Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Angioplasty Balloons Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. B. Braun Melsungen AG
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Biotronik SE And Co. KG
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Boston Scientific Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. C. R. Bard, Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Cardinal Health, Inc
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. MEDTRONIC PLC.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. MicroPort Scientific Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Terumo Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. THE SPECTRANETICS CORPORATION
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ANGIOPLASTY BALLOONS MARKET FOR NORMAL BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ANGIOPLASTY BALLOONS MARKET FOR DRUG ELUTING BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. ANGIOPLASTY BALLOONS MARKET FOR CUTTING BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. ANGIOPLASTY BALLOONS MARKET FOR SCORING BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 7. ANGIOPLASTY BALLOONS MARKET FOR PERIPHERAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ANGIOPLASTY BALLOONS MARKET FOR CORONARY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 10. ANGIOPLASTY BALLOONS MARKET FOR ASCS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. ANGIOPLASTY BALLOONS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. ANGIOPLASTY BALLOONS MARKET FOR CATH LABS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. ANGIOPLASTY BALLOONS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. U.S. ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 19. U.S. ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 20. U.S. ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. CANADA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 22. CANADA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 23. CANADA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 26. MEXICO ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. FRANCE ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 32. FRANCE ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 33. FRANCE ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 35. GERMANY ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 36. GERMANY ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. ITALY ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 38. ITALY ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 39. ITALY ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. SPAIN ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 41. SPAIN ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 42. SPAIN ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. UK ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 44. UK ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 45. UK ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 48. REST OF EUROPE ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. CHINA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 54. CHINA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 55. CHINA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 57. JAPAN ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 58. JAPAN ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. INDIA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 60. INDIA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 61. INDIA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 63. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 64. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 66. AUSTRALIA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 67. AUSTRALIA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 70. REST OF ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 77. BRAZIL ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 78. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 79. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 80. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 82. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 83. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 87. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 88. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 89. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 90. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 91. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 93. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 94. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 95. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 96. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
TABLE 98. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
TABLE 99. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
TABLE 100. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
TABLE 101. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 103. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 104. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 105. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 106. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. C. R. BARD, INC.: KEY EXECUTIVES
TABLE 108. C. R. BARD, INC.: COMPANY SNAPSHOT
TABLE 109. C. R. BARD, INC.: OPERATING SEGMENTS
TABLE 110. C. R. BARD, INC.: PRODUCT PORTFOLIO
TABLE 111. C. R. BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. CARDINAL HEALTH, INC: KEY EXECUTIVES
TABLE 113. CARDINAL HEALTH, INC: COMPANY SNAPSHOT
TABLE 114. CARDINAL HEALTH, INC: OPERATING SEGMENTS
TABLE 115. CARDINAL HEALTH, INC: PRODUCT PORTFOLIO
TABLE 116. CARDINAL HEALTH, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. MEDTRONIC PLC.: KEY EXECUTIVES
TABLE 118. MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 119. MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 120. MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 121. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 123. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 124. MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 125. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 126. MICROPORT SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 128. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 129. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 130. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 131. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. THE SPECTRANETICS CORPORATION: KEY EXECUTIVES
TABLE 133. THE SPECTRANETICS CORPORATION: COMPANY SNAPSHOT
TABLE 134. THE SPECTRANETICS CORPORATION: OPERATING SEGMENTS
TABLE 135. THE SPECTRANETICS CORPORATION: PRODUCT PORTFOLIO
TABLE 136. THE SPECTRANETICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ANGIOPLASTY BALLOONS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ANGIOPLASTY BALLOONS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANGIOPLASTY BALLOONS MARKET
FIGURE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION, BY TYPE
FIGURE 11. ANGIOPLASTY BALLOONS MARKET FOR NORMAL BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ANGIOPLASTY BALLOONS MARKET FOR DRUG ELUTING BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. ANGIOPLASTY BALLOONS MARKET FOR CUTTING BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. ANGIOPLASTY BALLOONS MARKET FOR SCORING BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION, BY APPLICATION
FIGURE 16. ANGIOPLASTY BALLOONS MARKET FOR PERIPHERAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. ANGIOPLASTY BALLOONS MARKET FOR CORONARY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION, BY END USER
FIGURE 19. ANGIOPLASTY BALLOONS MARKET FOR ASCS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. ANGIOPLASTY BALLOONS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. ANGIOPLASTY BALLOONS MARKET FOR CATH LABS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 26. COMPETITIVE DASHBOARD
FIGURE 27. COMPETITIVE HEATMAP: ANGIOPLASTY BALLOONS MARKET
FIGURE 28. TOP PLAYER POSITIONING, 2023
FIGURE 29. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. B. BRAUN MELSUNGEN AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. BIOTRONIK SE AND CO. KG: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. C. R. BARD, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. C. R. BARD, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. C. R. BARD, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. CARDINAL HEALTH, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. CARDINAL HEALTH, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. CARDINAL HEALTH, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. MEDTRONIC PLC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. MICROPORT SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. THE SPECTRANETICS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. THE SPECTRANETICS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. THE SPECTRANETICS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc
  • MEDTRONIC PLC.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • THE SPECTRANETICS CORPORATION

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information